U.S. Physical Therapy, Inc.
USPH
$80.84
-$2.14-2.58%
| Weiss Ratings | USPH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | B- | |||
| Rating Factors | USPH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Fair | |||
| Growth Index | Good | |||
| Efficiency Index | Good | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | USPH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.76 | |||
| Price History | USPH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -7.84% | |||
| 30-Day Total Return | -11.05% | |||
| 60-Day Total Return | -15.86% | |||
| 90-Day Total Return | -0.82% | |||
| Year to Date Total Return | -8.01% | |||
| 1-Year Total Return | -21.75% | |||
| 2-Year Total Return | -12.70% | |||
| 3-Year Total Return | -10.21% | |||
| 5-Year Total Return | -12.94% | |||
| 52-Week High % Change | -26.97% | |||
| 52-Week Low % Change | 8.93% | |||
| Price | USPH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $113.63 | |||
| 52-Week Low Price | $76.18 | |||
| 52-Week Low Price (Date) | Oct 07, 2024 | |||
| 52-Week High Price (Date) | Apr 01, 2024 | |||
| Valuation | USPH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 1.26B | |||
| Enterprise Value | 1.78B | |||
| Price/Earnings (TTM) | 45.08 | |||
| Earnings Per Share (TTM) | 1.84 | |||
| Earnings Per Share Growth | 37.38% | |||
| Price/Earnings To Growth | 1.21 | |||
| Price/Sales (TTM) | 1.88 | |||
| Price/Book (Q) | 2.56 | |||
| Enterprise Value/Revenue (TTM) | 2.68 | |||
| Price | $80.84 | |||
| Enterprise Value/EBITDA (TTM) | 20.26 | |||
| Enterprise Value/EBIT | 25.72 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | USPH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 15.09M | |||
| Dividend Yield | 2.12% | |||
| Div. Per Share (Most Recent) | $0.44 | |||
| Dividend Per Share (TTM) | $1.76 | |||
| Payout Ratio (TTM) | 84.46% | |||
| Dividend Per Share (Most Recent) | $0.44 | |||
| Company Info | USPH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | (713) 297-7000 | |||
| Address | 1300 West Sam Houston Parkway South Houston, TX 77042 | |||
| Website | www.usph.com | |||
| Country | United States | |||
| Year Founded | 1990 | |||
| Profitability | USPH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 10.43% | |||
| Profit Margin | 4.72% | |||
| Management Effectiveness | USPH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 4.00% | |||
| Return on Equity | 6.46% | |||
| Income Statement | USPH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 553.64M | |||
| Total Revenue (TTM) | 664.43M | |||
| Revenue Per Share | $44.03 | |||
| Gross Profit (TTM) | 145.45M | |||
| EBITDA (TTM) | 87.99M | |||
| EBIT (TTM) | 69.31M | |||
| Net Income (TTM) | 31.42M | |||
| Net Income Avl. to Common (TTM) | 31.42M | |||
| Total Revenue Growth (Q YOY) | 16.56% | |||
| Earnings Growth (Q YOY) | 1,066.28% | |||
| EPS Diluted (TTM) | 1.84 | |||
| EPS Diluted Growth (Q YOY) | 236.93% | |||
| Balance Sheet | USPH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 43.11M | |||
| Cash Per Share (Q) | $2.86 | |||
| Total Current Assets (Q) | 137.58M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 759.05M | |||
| Current Ratio (Q) | 1.183 | |||
| Book Value Per Share (Q) | $32.39 | |||
| Total Assets (Q) | 1.17B | |||
| Total Current Liabilities (Q) | 116.28M | |||
| Total Debt (Q) | 295.23M | |||
| Total Liabilities (Q) | 408.42M | |||
| Total Common Equity (Q) | 488.93M | |||
| Cash Flow | USPH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -149.45M | |||
| Cash from Financing (TTM) | -36.95M | |||
| Net Change in Cash (TTM) | -111.46M | |||
| Levered Free Cash Flow (TTM) | 45.67M | |||
| Cash from Operations (TTM) | 74.94M | |||
